AbbVie raises 2027 sales forecast for new immunology drugs to $27 billion

FREE Breaking News Alerts from StreetInsider.com!

E-mail Address

StreetInsider.com Top Tickers, 6/23/2026

1. ABBV
2. MU
3. SPCX
4. IBM
5. ACN
6. NVDA
7. PRIM
8. META
9. SPY
10. TSLA

Go back to AbbVie raises 2027 sales forecast for new immunology drugs to $27 billion
AbbVie (NYSE: ABBV) Delayed: 233.64 +3.63 (1.58%)
Previous Close $230.01    52 Week High $68.12 
Open $232.97    52 Week Low $50.71 
Day High $234.71    P/E 50.68 
Day Low $231.30    EPS $4.61 
Volume 2,127,959